This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Allergic Conjunctivitis
and you are
over 10
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The present study will test if administration of different concentrations of 1334H eyedrops will be effective in treatment of allergic conjunctivitis in people with 10 yrs of age or older.

Provided treatments

  • Drug: SPARC1102 I
  • Drug: SPARC1102 II
  • Drug: SPARC1102 III
  • Drug: Vehicle

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01320553. The sponsor of the trial is Sun Pharma Advanced Research Company Limited and it is looking for 122 volunteers for the current phase.
Official trial title:
Effect of Different Concentrations of SPARC1102 on Allergic Conjunctivitis